Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy.
A FassioG PorcielloG CarioliE PalumboS VitaleA LuongoC MontagneseM PreteM GrimaldiR PicaE RotondoL FalzoneI CalabreseA MinopoliB GrilliM CuomoP C FiorilloC EvangelistaE CavalcantiM De LaurentiisD CiannielloC PacilioM PintoG ThomasM RinaldoM D'AiutoD SerrainoS MassarutA SteffanF FerraùR RosselloF MessinaF CatalanoG AdamiF BertoldoM LibraA CrispoE CelentanoC La VecchiaL S A AugustinD GattiPublished in: Reumatismo (2024)
Hypovitaminosis D in women recently diagnosed with BC and participating in a lifestyle trial in Italy was widespread and highest with obesity, hypertriglyceridemia, and chemotherapy use. Considering that hypovitaminosis D is a risk factor for lower efficacy of bone density treatments and possibly BC mortality, our results suggest the need to promptly address and treat vitamin D deficiency.
Keyphrases
- metabolic syndrome
- weight loss
- polycystic ovary syndrome
- phase iii
- study protocol
- insulin resistance
- clinical trial
- phase ii
- breast cancer risk
- physical activity
- cardiovascular disease
- pregnancy outcomes
- cardiovascular events
- bone mineral density
- locally advanced
- high fat diet induced
- open label
- adipose tissue
- body mass index
- pregnant women
- bone loss
- soft tissue
- newly diagnosed